Regulation of glucagon-like peptide-1-(7-36) amide, peptide YY, and neurotensin secretion by neurotransmitters and gut hormones in the isolated vascularly perfused rat ileum

• Published in: Endocrinology (Philadelphia) Vol. 136; no. 11; p. 5182
• Main Authors: Dumoulin, V, Dakka, T, Plaisancie, P, Chayvialle, J A, Cuber, J C
• Format: Journal Article
• Language: English
• Published: United States 01.11.1995
• Subjects: Animals; Bethanechol - pharmacology; Bombesin - pharmacology; Calcitonin Gene-Related Peptide - pharmacology; Gastric Inhibitory Polypeptide - pharmacology; Gastrointestinal Hormones - pharmacology; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Ileum - drug effects; Ileum - secretion; Isoproterenol - pharmacology; Male; Neurotensin - secretion; Neurotransmitter Agents - pharmacology; Parasympathomimetics - pharmacology; Peptide Fragments - secretion; Peptide YY; Peptides - secretion; Perfusion; Rats; Rats, Wistar; Tetrodotoxin - pharmacology
• ISSN: 0013-7227
• DOI: 10.1210/en.136.11.5182

Neurotensin (NT), peptide YY (PYY), and several peptides derived from proglucagon are promptly released from endocrine cells of the distal part of the gut after oral ingestion of a meal, thus suggesting that release of these peptides is partly under neural and/or hormonal control. Our previous studies conducted with a model of isolated vascularly perfused rat colon showed that colonic L cells are highly responsive to several transmitters of the gut and to the hormonal peptide GIP. To test the possibility that hormones produced by the proximal small intestine or transmitters of the enteric nervous system may also modulate the secretory activity of the ileal L cells, various intestinal regulatory peptides and neurotransmitters were administered intraarterially for 30 min in the isolated vascularly perfused rat ileum preparation. The secretory activity of the ileal N cells was comparatively assessed. The release of NT, PYY, and glucagon-like peptide-1 (GLP-1) in the portal effluent was measured with specific RIAs. The muscarinic cholinergic agonist bethanechol at a concentration of 10(-4) M provoked a biphasic release of PYY, GLP-1, and NT, consisting of an early peak followed by a sustained response. Similarly, bombesin (10(-7) M) induced a marked biphasic release of PYY and GLP-1. In contrast, the NT response was essentially monophasic, characterized by an early peak secretion. Tetrodotoxin did not modify the bombesin-induced release of PYY, GLP-1, and NT. The beta-adrenergic agonist isoproterenol at a concentration of 10(-6) M induced a transient rise in portal PYY and GLP-1 concentrations, whereas the effect on NT release was clearly biphasic. Calcitonin gene-related peptide (5 x 10(-8) M) induced a dramatic rise in PYY, GLP-1, and NT immunoreactivities in the portal effluent (peaks at 600%, 500%, and 550% of the basal values, respectively, 4 mi n after the start of infusion). Intraarterial infusion of GIP over the concentration range (0.5-3 nM) evoked a significant increase in portal concentration of the three peptides only at the threshold concentration of 3 nM. Secretin (50 pM) or cholecystokinin (50 pM) did not affect the release of ileal hormones. In conclusion, ileal L and N cells respond to a variety of transmitters of the gut. The pattern of peptide release depends on the cell type studied. The two cosynthesized peptides, PYY and GLP-1, appear to be cosecreted in the conditions of the present study.